The first case against a drug manufacturer for the national public health disaster may indicate what lies ahead in 2,000 more lawsuits. Source: NYT > Business – Jan Hoffman
McKinsey Advised Johnson & Johnson on Increasing Opioid Sales
In a trial in Oklahoma, records showed the firm was consulted about sales at a time when abuse of pain medicine was widespread. Cases in two other states also shed light on its role. Source: NYT > Business – Walt Bogdanich
Oklahoma Faces Off Against J & J in First Trial of an Opioid Maker
With Purdue Pharma and Teva settling the case, the state sought to hold J & J responsible for the broader opioid crisis. The company argued that it operated responsibly and lawfully. Source: NYT > Business – Jan Hoffman
Doctors Welcome New Depression Drug, Cautiously
Esketamine, the nasal-spray antidepressant recently approved by the F.D.A., is promising, but using it entails some practical challenges. Source: NYT > Business – BENEDICT CAREY